Telara Pharma

📍 Barcelona, Spain🗓 Founded 2020👥 7 employees💰 Last funded Dec 2025
Biotechnology Research🌐 telarapharmahealth.com
Website LinkedIn
At Telara Pharma, we develop innovative therapies based on cilastatin, a drug with a solid safety record and a powerful neuroprotective effect on the retina. Our goal is to transform glaucoma and diabetic retinopathy retreatments through a strategy that targets retinal neurodegeneration and inflammation—two key processes that current medicine does not address. Unlike therapies focused solely on reducing intraocular pressure (IOP), our ophthalmic drops directly protect retinal ganglion cells, preserving vision and quality of life.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Spain
1
Frequently asked questions
Who invested in Telara Pharma?
Telara Pharma has 1 investors on record on gritt.io, 1 mid-stage.
When did Telara Pharma last raise funding?
The most recent investment in Telara Pharma recorded on gritt.io was in December 2025.
When was Telara Pharma founded?
Telara Pharma was founded in 2020.
What industry is Telara Pharma in?
Telara Pharma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Telara Pharma based?
Telara Pharma is headquartered in Barcelona, Spain.